APOC2 and hypertriglyceridemia: Mutations in genes encoding lipoprotein lipase, apolipoprotein C-II (APOC2), apolipoprotein A-V (APOA5), and other enzymes involved in lipid metabolism have been associated with severe hypertriglyceridemia, particularly when triggered by medications or metabolic stress [18].